These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7628891)

  • 1. Infarct size limitation: acute N-acetylcysteine defense (ISLAND) trial. Start of the study.
    Sochman J; Vrbská J; Musilová B; Rocek M
    Int J Cardiol; 1995 Apr; 49(2):181-2. PubMed ID: 7628891
    [No Abstract]   [Full Text] [Related]  

  • 2. Infarct Size Limitation: acute N-acetylcysteine defense (ISLAND trial): preliminary analysis and report after the first 30 patients.
    Sochman J; Vrbská J; Musilová B; Rocek M
    Clin Cardiol; 1996 Feb; 19(2):94-100. PubMed ID: 8821417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.
    de Boer MJ; Suryapranata H; Hoorntje JC; Reiffers S; Liem AL; Miedema K; Hermens WT; van den Brand MJ; Zijlstra F
    Circulation; 1994 Aug; 90(2):753-61. PubMed ID: 8044944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total recovery of left ventricular function after acute myocardial infarction: comprehensive therapy with streptokinase, N-acetylcysteine and percutaneous transluminal coronary angioplasty.
    Sochman J; Peregrin JH
    Int J Cardiol; 1992 Apr; 35(1):116-8. PubMed ID: 1563867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction.
    Clemmensen P; Ohman EM; Sevilla DC; Wagner NB; Quigley PS; Grande P; Wagner GS
    Am J Cardiol; 1992 Dec; 70(18):1391-6. PubMed ID: 1442606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial.
    Marino P; Zanolla L; Zardini P
    J Am Coll Cardiol; 1989 Nov; 14(5):1149-58. PubMed ID: 2681320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
    Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
    Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous streptokinase for acute myocardial infarction reduces the occurrence of ventricular late potentials.
    Chew EW; Morton P; Murtagh JG; Scott ME; O'Keeffe DB
    Br Heart J; 1990 Jul; 64(1):5-8. PubMed ID: 2390403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function.
    Sezer M; Cimen A; Aslanger E; Elitok A; Umman B; Buğra Z; Yormaz E; Türkmen C; Adalet IS; Nişanci Y; Umman S
    J Am Coll Cardiol; 2009 Sep; 54(12):1065-71. PubMed ID: 19744615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
    Zijlstra F; de Boer MJ; Hoorntje JC; Reiffers S; Reiber JH; Suryapranata H
    N Engl J Med; 1993 Mar; 328(10):680-4. PubMed ID: 8433726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
    Vermeer F; Simoons ML; Bär FW; Tijssen JG; van Domburg RT; Serruys PW; Verheugt FW; Res JC; de Zwaan C; van der Laarse A
    Circulation; 1986 Dec; 74(6):1379-89. PubMed ID: 3779921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic treatment of myocardial infarction. Data on the limitation of infarction size and left ventricular function].
    Barraud P; Marcaggi X; Boueyre M; Schandrin C; Regeard E; Maublant J; Lusson JR; Cassagnes J
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):689-95. PubMed ID: 1530410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angioplasty vs thrombolysis in acute MI.
    Millard PS
    J Fam Pract; 1997 Jul; 45(1):21-2. PubMed ID: 9228907
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.
    de Boer MJ; Hoorntje JC; Ottervanger JP; Reiffers S; Suryapranata H; Zijlstra F
    J Am Coll Cardiol; 1994 Apr; 23(5):1004-8. PubMed ID: 8144761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size.
    Pizzetti G; Belotti G; Margonato A; Carlino M; Gerosa S; Carandente O; Chierchia SL
    Eur Heart J; 1996 Mar; 17(3):421-8. PubMed ID: 8737217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.